You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Everolimus

Showing 26 - 50 of 1,264
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

Not yet recruiting
  • Metastatic Midgut Neuroendocrine Tumor
  • Unresectable Midgut Neuroendocrine Tumor
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Mar 16, 2023

Stability of Tacrolimus, Cyclosporine A, Everolimus and

Completed
  • Transplantation Drugs Stability
  • Blood sampling
  • Turin, Italy
    AOU Città della Salute e della Scienza di Torino/S.C Biochimica
Oct 6, 2022

Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in United States (Everolimus, Nelarabine, Cyclophosphamide)

Recruiting
  • Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Everolimus
  • +3 more
  • Atlanta, Georgia
  • +3 more
Aug 18, 2022

Breast Cancer Trial in United States (ARV-471 in combination with Everolimus)

Not yet recruiting
  • Breast Cancer
  • ARV-471 in combination with Everolimus
  • San Diego, California
  • +4 more
Aug 12, 2022

Renal Cell Carcinoma Trial in Iowa City (Lenvatinib, Everolimus, Partial or Radical Cytoreductive Nephrectomy)

Recruiting
  • Renal Cell Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
May 4, 2022

Thyroid Cancer Trial in United States (sorafenib with everolimus)

Active, not recruiting
  • Thyroid Cancer
  • sorafenib with everolimus
  • Basking Ridge, New Jersey
  • +3 more
Jul 1, 2022

Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)

Completed
  • Diffuse Intrinsic Pontine Glioma
  • +6 more
  • Washington, District of Columbia
  • +6 more
Jan 12, 2023

Breast Cancer Stage IIB Trial in Philadelphia (Hydroxychloroquine, Everolimus)

Recruiting
  • Breast Cancer Stage IIB
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 8, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • +4 more
  • Aurora, Colorado
  • +1 more
Sep 8, 2022

Breast Cancer, Hormone Receptor Positive Tumor Trial in Germany (3 weeks Dose Induction of Everolimus, 3 weeks Conventional

Completed
  • Breast Cancer
  • Hormone Receptor Positive Tumor
  • 3 weeks Dose Induction of Everolimus
  • +3 more
  • Neu Isenburg, Hessen, Germany
  • +13 more
Feb 22, 2022

Renal Transplant Trial in Toledo (Arm 1 Everolimus/Reduced dose tacrolimus)

Completed
Has Results
  • Renal Transplant
  • Arm 1 Everolimus/Reduced dose tacrolimus
  • Toledo, Ohio
    University of Toledo, Health Science Campus
May 2, 2022

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative Trial in Duarte, Rancho Cucamonga, South Pasadena

Completed
Has Results
  • Estrogen Receptor Negative
  • +4 more
  • everolimus
  • +3 more
  • Duarte, California
  • +2 more
Jun 6, 2022

Coronary Artery Disease Trial in Fribourg (Implantation of everolimus-eluting bioresorbable vascular scaffold stent,

Completed
  • Coronary Artery Disease
  • Implantation of everolimus-eluting bioresorbable vascular scaffold stent
  • +2 more
  • Fribourg, Switzerland
    Fribourg Cantonal Hospital
Oct 14, 2021

Acute Lymphoblastic Leukemia Trial in United States (Everolimus, Prednisone, Vincristine)

Completed
  • Acute Lymphoblastic Leukemia
  • Everolimus
  • +5 more
  • San Francisco, California
  • +7 more
Aug 5, 2022

Pharmacokinetics Trial in Seoul (SVG101 (T), Afinitor (R))

Completed
  • Pharmacokinetics
  • SVG101 (T)
  • Afinitor (R)
  • Seoul, Korea, Republic of
    Yonsei University Healthcare System, Severance Hospital
Aug 3, 2022

Renal Cell Carcinoma Trial (Cabozantinib, Ipilimumab, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jun 9, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Ischemic Heart Disease Trial in Seoul (Implanatation of Genoss DES sirolimus-eluting coronary system, Implanatation of Xience

Recruiting
  • Ischemic Heart Disease
  • Implanatation of Genoss DES sirolimus-eluting coronary system
  • Implanatation of Xience DES everolimus-eluting coronary system
  • Seoul, Korea, Republic of
    Cardiac and Vascular Center; Samsung Medical Center
Jun 29, 2022

Advanced Breast Cancer Trial in China (Everolimus, Exemestane, Everolimus Placebo)

Completed
  • Advanced Breast Cancer
  • Everolimus
  • +2 more
  • Guangzhou, Guangdong, China
  • +14 more
Jun 17, 2022

Breast Cancer Trial in New Haven (Everolimus)

Terminated
Has Results
  • Breast Cancer
  • Everolimus
  • New Haven, Connecticut
    Yale University
Jan 12, 2022

Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)

Completed
  • Bladder Cancer
  • Metastatic Transitional Cell Carcinoma
  • Everolimus
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 16, 2021

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Everolimus
  • +2 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Everolimus
  • +4 more
  • San Francisco, California
  • +8 more
Jul 19, 2022

Solid Tumours, Multiple Myeloma, Lung Cancer Trial in Sutton, London (VS-6766, Everolimus)

Recruiting
  • Solid Tumours
  • +2 more
  • Sutton, Surrey, United Kingdom
  • +1 more
Apr 25, 2022

Breast Tumors, Endocrine Breast Diseases, Tumor Metastasis Trial in Baltimore (letrozole, lapatinib, everolimus)

Terminated
Has Results
  • Breast Neoplasms
  • +2 more
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
Feb 9, 2022